Viome
Provides the industry’s only direct-to-consumer healthcare test that analyzes microbial and human gene expressions (mRNA).
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
* | $25.0m Valuation: $335m | Series D | |
| Total Funding | 000k | ||
| USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 58 % | 3 % | 12 % | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Viome operates in the health and wellness market, focusing on personalized nutrition and gut health solutions. The company serves individuals seeking to optimize their health through tailored dietary and supplement recommendations. Viome's core business model revolves around offering health tests that analyze the microbiome and cellular health, providing personalized insights and nutrition plans based on the results. The company leverages advanced mRNA technology and artificial intelligence to deliver precise health recommendations. Revenue is generated through the sale of health tests, personalized supplements, and probiotics subscriptions. Viome's target market includes health-conscious consumers looking for data-driven, personalized health solutions.
Keywords: microbiome, personalized nutrition, gut health, mRNA technology, AI platform, health tests, probiotics, supplements, cellular health, wellness.
Tech stack
Investments by Viome
Edit